We are live on ! Find out more
SBII

Sandbridge X2 Corp.

Delisted

SBII was delisted on the 29th of November, 2022.

70 hedge funds and large institutions have $179M invested in Sandbridge X2 Corp. in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

0% more capital invested

Capital invested by funds: $179M → $179M (+$467K)

0% more funds holding

Funds holding: 7070 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

Holders
70
Holders Change
Holders Change %
0%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
10
Reduced
7
Closed
8
Calls
Puts
Net Calls
Net Calls Change

SBII Hedge Fund Activity: Q1 2022 in Review

70 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Sandbridge X2 Corp. (SBII) for Q1 2022, worth a combined $179M — up 0.26% from $179M a quarter earlier.

Fund positioning in SBII was balanced in Q1 2022: 8 funds opened new positions, 8 closed out, 10 added to existing stakes and 7 trimmed.

The largest buyer was Basso Capital Management, adding an estimated $2.43M. The largest seller was Beryl Capital Management, exiting entirely with an estimated $4.86M sold.

  • 70 institutional investors held Sandbridge X2 Corp. (SBII) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $179M of Sandbridge X2 Corp. stock for Q1 2022, up 0.26% quarter-over-quarter.
  • 8 funds opened new Sandbridge X2 Corp. positions in Q1 2022 and 8 closed out, a net change of 0 holders.
  • The largest Sandbridge X2 Corp. buyer in Q1 2022 was Basso Capital Management, an estimated $2.43M added.
  • The largest Sandbridge X2 Corp. seller in Q1 2022 was Beryl Capital Management, an estimated $4.86M sold.

Based on aggregated 13F filings for Q1 2022.